Researchers at the University of Toronto using PET imaging discovered that long COVID patients have significantly reduced dopamine-releasing nerve terminals in brain regions linked to motivation, memory, and movement, providing the first biological marker for the condition. The finding, led by psychiatry professor Jeffrey Meyer, shows a strong correlation between dopamine loss and specific symptoms like brain fog and fatigue, potentially opening pathways for targeted treatments.